« Return to News | Clinical Intelligence

The CenterWatch Monthly, December 2012

Monday, December 3, 2012 09:00 AM

Publicity, regulation tightening reins on use of KOLs

Doctors used to consider it an honor to be chosen as “key opinion leaders” (KOLs) by life sciences companies. They were able to help develop new treatments. They garnered the prestige of being considered thought leaders in their areas. And they got paid, sometimes quite handsomely. Drug and device makers, in return, received advice that helped them attune products to what patients really needed. And they basked in the prestige of the most respected medical figures. But bad press and congressional investigations into the cozy relationship between doctors and drug sponsor companies have changed the…

 

Time may be right to makeover the investigator brochure

In drug development, the investigator’s brochure (IB) has long served as the central reference document about an investigational product. It is intended to equip clinical researchers with what they need to make an unbiased risk-benefit assessment of the experimental medicine involving human subjects. But by virtue of its size and complexity, the IB rarely gets a thorough reading, and anecdotal evidence suggests the time and expense invested in its creation reap a relatively modest return. Rethinking the way the IB is developed and utilized may present major opportunities to educate study staff and motivate enrollment, as well as help detect and deter potential…

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.